Skip to content

RANI THERAPEUTICS HOLDINGS, INC.

RANI

CIK 0001856725

← back to feed
Revenue (TTM)
$1.88M
+58.9% YoY Q1 Mar 2026
Net Income (TTM)
−$26.4M
+1.1% YoY Q1 Mar 2026
EPS Diluted (TTM)
−$0.56
+57.1% YoY Q1 Mar 2026
Gross Margin
—
Q1 Mar 2026
Operating Margin
-2,027.3%
Q1 Mar 2026
Net Margin
-1,404.3%
Q1 Mar 2026
Free Cash Flow (TTM)
−$36.53M
Q1 Mar 2026
Cash
$9.64M
Q1 Mar 2026
Total Debt
$0
Q1 Mar 2026
Shares Outstanding
—
Q1 Mar 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings